Burning Rock Biotech (BNR) Non-Current Debt (2019 - 2025)

Burning Rock Biotech (BNR) recorded quarterly Non-Current Debt of $239687.4 in Q4 2025, down 5.26% quarter-over-quarter from $253000.0 in Q3 2025.

Burning Rock Biotech (BNR) Non-Current Debt (2019 - 2025) Analysis & Trends

Burning Rock Biotech's Non-Current Debt history runs 5 years deep, the most recent figure standing at $239687.4 for Q4 2025.

In Q4 2025, Non-Current Debt changed N/A year-over-year to $239687.4; the TTM figure through Dec 2025 stood at $239687.4 (changed N/A YoY), while the FY2025 annual figure was $243000.0, changed N/A from the prior year.
Non-Current Debt was $239687.4 for Q4 2025 at Burning Rock Biotech, down from $253000.0 in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $208.6 million in Q2 2022 to a low of $239687.4 in Q4 2025.
Historically, Non-Current Debt has averaged $69.9 million across 3 years, with a median of $253000.0 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	4.86 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	40.07 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	17.56 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	299.85 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	-
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	-
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	13.99 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	1.49 Bn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	2.16 Bn
10	Burning Rock Biotech	20.64 Mn	-47.19 Mn	14.10 Mn	239,687.42

Download Data